KNIGHT v. BOEHRINGER INGELHEIM PHARMACEUTICALS

No. 19-1636.

984 F.3d 329 (2021)

Claude R. KNIGHT; Claudia Stevens, individually and as Personal Representative of the Estate of Betty Erelene Knight; Betty Erelene Knight, Deceased, Plaintiffs-Appellees, v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Defendant-Appellant.

United States Court of Appeals, Fourth Circuit.

Decided: January 6, 2021.


Attorney(s) appearing for the Case

ARGUED: Paul Schmidt , COVINGTON & BURLING LLP, Washington, D.C., for Appellant. James Darren Summerville , SUMMERVILLE FIRM, LLC, Atlanta, Georgia, for Appellees. ON BRIEF: Phyllis A. Jones , COVINGTON & BURLING LLP, Washington, D.C.; Adam H. Charnes , Thurston H. Webb , KILPATRICK TOWNSEND & STOCKTON LLP, Winston-Salem, North Carolina, for Appellant. C. Andrew Childers , Emily T. Acosta , CHILDERS SCHLUETER & SMITH, Atlanta, Georgia; Neal L. Moskow , URY & MOSKOW, LLC, Fairfield, Connecticut, for Appellees.

Reversed by published opinion. Judge Quattlebaum wrote the opinion, in which Judge Niemeyer and Judge Diaz joined.


Under the preemption doctrine, a state-law challenge to federally approved pharmaceutical warning labels may only proceed when the pharmaceutical company has the unilateral ability to change that labeling. The Food and Drug Administration's changes-being-effected ("CBE") regulation...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases